• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Reporting of maltreatment for prenatal exposure similar among racial groups

byJames GrayandLeah Carr, MD
August 12, 2016
in Pediatrics
Reading Time: 3 mins read
Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Share on FacebookShare on Twitter

1. Black and Hispanic infants prenatally exposed to substances were not reported to child protection authorities at higher rates than white infants.

2. Any infant with in utero substance exposure was significantly more likely to be reported to child protection when compared to unexposed infants.

Evidence Rating Level: 2 (Good)                       

Study Rundown: Black infants have a higher rate of substantiated child maltreatment claims than white or Hispanic infants. This discrepancy may be due to a multitude of factors, including socioeconomic status and variability in reporting due to race. It is challenging to investigate the role that bias may play in initial reporting of child maltreatment, but the data surrounding prenatal substance exposure and subsequent reporting to child protection authorities provides an opportunity to evaluate racial bias in reporting. In this study, authors examined reporting of child maltreatment for prenatal substance exposure among black, Hispanic and white infants. The highest prevalence of substance exposure was found among black infants, followed by white and Hispanic infants. In an adjusted multivariate analysis, black and Hispanic infants exposed to substances were not reported to child protection authorities at significantly different rates to white infants. This study is particularly robust as it used linked data sets: the same cohort of infants was compared between hospital, child maltreatment and public health birth databases. However, it did not control for the possibility of bias in the initial screening of infants for exposure and examined only Californian infants in 2006. While these findings may be reassuring, physicians should remain vigilant against unconscious racial and ethnic bias in both testing and reporting of maltreatment.

Click to read the study, published today in Pediatrics

Relevant Reading: The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida

RELATED REPORTS

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

South Asian and Black populations disproportionately affected by COVID-19 in the United Kingdom  

In-Depth [retrospective cohort study]: A total of 474 071 black, Hispanic and white infants born in California in 2006 were individually linked across birth records, hospital discharges and child protection reports. Authors examined the likelihood of a child maltreatment report in the first 28 days of life based on maternal race or ethnicity (i.e., black, Hispanic or white) and a diagnosis of in substance exposure (either in the maternal or child medical record). Adjustments were made for various covariates including maternal age, insurance, prenatal care, birth order and infant birth weight. After controlling for covariates, infants with substance exposure were more likely to be reported to authorities (RR 10.9, 95%CI: 10.03-11.74). There was no significant difference in the rate of reporting families of black or white infants with exposure to one or multiple substances (RR 0.96, 95%CI: 0.86-1.06; RR 0.91, 95%CI: 0.78-1.05, respectively). Similarly, there was no significant difference in the adjusted rate of reporting between Hispanic and white infants with exposure to one or multiple substances (RR 0.93, 95%CI: 0.85-1.01; RR 0.90, 95%CI: 0.80-1.00). However, in data not adjusted for socioeconomic status and pregnancy risk factors, black and Hispanic infants were reported at significantly higher rates than white infants (RR 1.15, 95% CI: 1.08–1.21; RR 1.13, 95% CI: 1.08–1.18).

Image: CC/Wiki/Infantcentre

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: child abuse and neglectracial differencessubstance exposure
Previous Post

Thymectomy effective in patients with non-thymomatous myasthenia gravis: The MGTX trial

Next Post

Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation

RelatedReports

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US
StudyGraphics

#VisualAbstract: Melanoma may be considerably over-diagnosed in white patients in the US

March 24, 2022
Small-molecule inhibitor may enhance recovery after brain hemorrhage [PreClinical]
Emergency

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

August 27, 2021
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Infectious Disease

South Asian and Black populations disproportionately affected by COVID-19 in the United Kingdom  

May 19, 2021
Emergency

Greater rates of mortality linked to infants at risk for maltreatment

January 29, 2018
Next Post
Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation

Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation

Late gestation antidepressant use linked to postpartum hemorrhage

Forceps simulation associated with reduction in severe perineal lacerations

Standardized developmental screening of refugee children is recommended

Standardized developmental screening of refugee children is recommended

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow
  • 2MM: Longevity Roundup – Sleep patterns track with biological aging, earlier menopause signals cognitive decline, diet predicts aging-related mortality, and lifestyle intervention preserves mobility in frailty
  • 2 Minute Medicine Rewind September 21, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.